Proligodendroblast antigen (POA), a developmental antigen expressed by A007/O4-positive oligodendrocyte progenitors prior to the appearance of sulfatide and galactocerebroside
- PMID: 1573402
- DOI: 10.1111/j.1471-4159.1992.tb10967.x
Proligodendroblast antigen (POA), a developmental antigen expressed by A007/O4-positive oligodendrocyte progenitors prior to the appearance of sulfatide and galactocerebroside
Abstract
Evidence is presented for the immunological identification of a developmental antigen appearing at a critical point in the oligodendroglial lineage. Specifically, monoclonal antibody A007 recognizes cells in the oligodendrocyte lineage at two distinct stages. Analyses of purified lipid standards and lipid extracts from galactocerebroside-positive (GalC+) oligodendrocytes by enzyme-linked immunosorbent assay, lipid dot blot, and immuno-TLC demonstrated that A007 recognizes sulfatide (SUL) and seminolipid. However, neither 35SO4 incorporation into SUL nor SUL accumulation could be detected in A007-positive cells lacking galactocerebroside (i.e., A007+GalC- progenitor cells) present early in development. These data suggest that A007 also recognizes an antigen, named proligodendroblast antigen (POA), that appears during the late stage of oligodendrocyte progenitor development prior to the expression by oligodendrocytes of SUL and GalC. We have previously reported that monoclonal antibody O4 also recognizes not only SUL and seminolipid, but in addition an antigen that appears prior to the expression of SUL and galactocerebroside. In the present study all A007+ cells were also O4+ (and vice versa), and the developmental patterns of the two antibodies appeared to be identical. We conclude that (1) A007 is similar or identical to O4 with respect to its antigenic specificity, and (2) during oligodendrocyte lineage progression both antibodies react first with antigen POA on the surface of the oligodendrocyte progenitor cell prior to the expression of SUL [i.e., A007+O4+(POA+)SUL-GalC- proligodendroblasts], and only later with SUL as terminally differentiating oligodendrocytes emerge (i.e., A007+O4+SUL+GalC+ oligodendrocytes).
Similar articles
-
Novel oligodendrocyte transmembrane signaling systems. Investigations utilizing antibodies as ligands.Mol Neurobiol. 1993 Spring;7(1):1-22. doi: 10.1007/BF02780606. Mol Neurobiol. 1993. PMID: 8391270 Review.
-
Novel stage in the oligodendrocyte lineage defined by reactivity of progenitors with R-mAb prior to O1 anti-galactocerebroside.J Neurosci Res. 1992 Jul;32(3):309-16. doi: 10.1002/jnr.490320303. J Neurosci Res. 1992. PMID: 1433382
-
Stage specific, (O4+GalC-) isolated oligodendrocyte progenitors produce MBP+ myelin in vivo.Dev Neurosci. 1992;14(2):93-7. doi: 10.1159/000111652. Dev Neurosci. 1992. PMID: 1382941
-
04 and A007-sulfatide antibodies bind to embryonic Schwann cells prior to the appearance of galactocerebroside; regulation of the antigen by axon-Schwann cell signals and cyclic AMP.Development. 1990 May;109(1):105-16. doi: 10.1242/dev.109.1.105. Development. 1990. PMID: 2170096
-
Genetic dissection of myelin galactolipid function.J Neurocytol. 1999 Apr-May;28(4-5):271-9. doi: 10.1023/a:1007049310758. J Neurocytol. 1999. PMID: 10739570 Review.
Cited by
-
ERK1/ERK2 MAPK signaling is required to increase myelin thickness independent of oligodendrocyte differentiation and initiation of myelination.J Neurosci. 2012 Jun 27;32(26):8855-64. doi: 10.1523/JNEUROSCI.0137-12.2012. J Neurosci. 2012. PMID: 22745486 Free PMC article.
-
Identification of the Lipid Antigens Recognized by rHIgM22, a Remyelination-Promoting Antibody.Neurochem Res. 2023 Jun;48(6):1783-1797. doi: 10.1007/s11064-023-03859-2. Epub 2023 Jan 25. Neurochem Res. 2023. PMID: 36695984
-
Motor Learning and Physical Exercise in Adaptive Myelination and Remyelination.ASN Neuro. 2022 Jan-Dec;14:17590914221097510. doi: 10.1177/17590914221097510. ASN Neuro. 2022. PMID: 35635130 Free PMC article. Review.
-
Tenascin-R is an intrinsic autocrine factor for oligodendrocyte differentiation and promotes cell adhesion by a sulfatide-mediated mechanism.J Neurosci. 1997 Jun 15;17(12):4642-51. doi: 10.1523/JNEUROSCI.17-12-04642.1997. J Neurosci. 1997. PMID: 9169525 Free PMC article.
-
Novel oligodendrocyte transmembrane signaling systems. Investigations utilizing antibodies as ligands.Mol Neurobiol. 1993 Spring;7(1):1-22. doi: 10.1007/BF02780606. Mol Neurobiol. 1993. PMID: 8391270 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical